The US Food and Drug Administration (FDA) has recommended voluntary recall of certain extended-release (ER) versions of metformin because testing has revealed excessive levels of ...
Two pharmaceutical companies recently issued voluntary recalls for extended-release versions of the diabetes drug metformin, because it may contain high levels of a cancer-causing chemical, according ...
Apotex has recalled all its Metformin Hydrochloride Extended-Release Tablets 500 mg in the United States for too much of carcinogen NDMA, the same “impurity” that got all the Zantac yanked earlier ...
Apotex Corp is voluntarily recalling all lots of Metformin Hydrochloride Extended-Release Tablets, USP 500mg within expiry to retail level. Apotex was notified by the U.S. Food and Drug Administration ...
Two pharmaceutical companies recently issued voluntary recalls for extended-release versions of the diabetes drug metformin, because it may contain high levels of a cancer-causing chemical, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback